New test provides fast and accurate diagnosis of liposarcomas

Researchers have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma. It quickly and reliably distinguishes benign lipomas from liposarcomas and can be performed in laboratories at a lower cost than current “gold standard” tests. The new assay is described in The Journal of Molecular Diagnostics.

Read more: https://www.elsevier.com/about/press-releases/research-and-journals/new-test-provides-fast-and-accurate-diagnosis-of-liposarcomas